Cargando…
Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
Malignant phyllodes tumor is a rare breast tumor, with distant metastases and heterologous differentiation in a few cases. We report a case of malignant phyllodes tumor with liposarcomatous differentiation in the primary tumor and osteosarcomatous differentiation in the lung metastatic tumor. A midd...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070992/ https://www.ncbi.nlm.nih.gov/pubmed/37025961 http://dx.doi.org/10.3389/fmed.2023.1141353 |
_version_ | 1785019103489032192 |
---|---|
author | Liu, Ruijing Xue, Jingli Liu, Wen Jiang, Beibei Shi, Fuyun Wang, Zhenzheng Li, Peifeng |
author_facet | Liu, Ruijing Xue, Jingli Liu, Wen Jiang, Beibei Shi, Fuyun Wang, Zhenzheng Li, Peifeng |
author_sort | Liu, Ruijing |
collection | PubMed |
description | Malignant phyllodes tumor is a rare breast tumor, with distant metastases and heterologous differentiation in a few cases. We report a case of malignant phyllodes tumor with liposarcomatous differentiation in the primary tumor and osteosarcomatous differentiation in the lung metastatic tumor. A middle-aged female presented with a well-defined mass in the upper lobe of the right lung measuring 5.0 × 5.0 × 3.0 cm. The patient had a history of malignant phyllodes tumor in the breast. The patient underwent a right superior lobectomy. Histologically, the primary tumor was a typical malignant phyllodes tumor with pleomorphic liposarcomatous differentiation, while the lung metastasis showed osteosarcomatous differentiation without original biphasic features. The phyllodes tumor and heterologous components showed CD10 and p53 expression, and were negative for ER, PR, and CD34. Exome sequencing revealed TP53, TERT, EGFR, RARA, RB1, and GNAS mutations in all three components. Although the lung metastasis were morphologically different from the primary breast tumor, their common origin was demonstrated through immunohistochemical and molecular characterization. Cancer stem cells give rise to tumor heterogeneous cells, and heterologous components in malignant phyllodes tumors may indicate unfavorable prognosis and a greater risk of early recurrence and metastasis. |
format | Online Article Text |
id | pubmed-10070992 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100709922023-04-05 Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor Liu, Ruijing Xue, Jingli Liu, Wen Jiang, Beibei Shi, Fuyun Wang, Zhenzheng Li, Peifeng Front Med (Lausanne) Medicine Malignant phyllodes tumor is a rare breast tumor, with distant metastases and heterologous differentiation in a few cases. We report a case of malignant phyllodes tumor with liposarcomatous differentiation in the primary tumor and osteosarcomatous differentiation in the lung metastatic tumor. A middle-aged female presented with a well-defined mass in the upper lobe of the right lung measuring 5.0 × 5.0 × 3.0 cm. The patient had a history of malignant phyllodes tumor in the breast. The patient underwent a right superior lobectomy. Histologically, the primary tumor was a typical malignant phyllodes tumor with pleomorphic liposarcomatous differentiation, while the lung metastasis showed osteosarcomatous differentiation without original biphasic features. The phyllodes tumor and heterologous components showed CD10 and p53 expression, and were negative for ER, PR, and CD34. Exome sequencing revealed TP53, TERT, EGFR, RARA, RB1, and GNAS mutations in all three components. Although the lung metastasis were morphologically different from the primary breast tumor, their common origin was demonstrated through immunohistochemical and molecular characterization. Cancer stem cells give rise to tumor heterogeneous cells, and heterologous components in malignant phyllodes tumors may indicate unfavorable prognosis and a greater risk of early recurrence and metastasis. Frontiers Media S.A. 2023-03-21 /pmc/articles/PMC10070992/ /pubmed/37025961 http://dx.doi.org/10.3389/fmed.2023.1141353 Text en Copyright © 2023 Liu, Xue, Liu, Jiang, Shi, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Liu, Ruijing Xue, Jingli Liu, Wen Jiang, Beibei Shi, Fuyun Wang, Zhenzheng Li, Peifeng Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
title | Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
title_full | Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
title_fullStr | Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
title_full_unstemmed | Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
title_short | Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
title_sort | case report: osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070992/ https://www.ncbi.nlm.nih.gov/pubmed/37025961 http://dx.doi.org/10.3389/fmed.2023.1141353 |
work_keys_str_mv | AT liuruijing casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor AT xuejingli casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor AT liuwen casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor AT jiangbeibei casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor AT shifuyun casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor AT wangzhenzheng casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor AT lipeifeng casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor |